High materiality7/10
Astrana Health initiated with an Outperform at Oppenheimer
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer initiates ASTH with Outperform; target $53 vs current $39.60; price change since signal -2.32.
- ASTH: Outperform from Oppenheimer; tgt $53; price $39.60.
Key facts
- 01
Target: $53
- 02
Posted price: $39.6
- 03
Analyst firm: Oppenheimer
- 04
Analyst: Michael Wiederhorn
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.